FDA Advisory Panel Rejects Biden Plan for Pfizer Booster Shots, But Approves Them for Elderly and High-Risk Individuals

Photo by KENZO TRIBOUILLARD/AFP via Getty Images.

An advisory panel at the Food and Drug Administration rejected on Friday a plan to offer booster shots of the Pfizer-BioNTech coronavirus vaccine to Americans age 16 and older.

The final vote tally of the Vaccines and Related Biological Products Advisory Committee was 16 to 2. The vote is nonbinding. A final FDA decision is expected soon.

“Over several hours of discussion, members of the Food and Drug Administration
Read more…

Please follow and like us: